IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme

Only 2% of glioblastoma multiforme (GBM) patients respond to standard therapy and survive beyond 36 months (long-term survivors, LTS), while the majority survive less than 12 months (short-term survivors, STS). To understand the mechanism leading to poor survival, we analyzed publicly available data...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Genet
Hoofdauteurs: Kalya, Manasa, Kel, Alexander, Wlochowitz, Darius, Wingender, Edgar, Beißbarth, Tim
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2021
Onderwerpen:
Genetics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239365/
https://ncbi.nlm.nih.gov/pubmed/34211498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2021.670240
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items